1. Detection of pathogenic variants related to severe dominant monogenic diseases by non-invasive prenatal testing (NIPT-SGD)
Nội dung chính của bài viết
Tóm tắt
Non-invasive prenatal testing (NIPT) as a screening method for common chromosomal abnormalities such as trisomy 21, 18, and 13 has been widely adopted. In the last five years, the possibility of NIPT to detect common single-gene disorders (SGD) due to de novo mutations or paternal inherited had been reported worldwide. Our report describes the first cases in Vietnam that identified pathogenic/likely pathogenic variants by NIPT-SGD in fetuses. These findings were compared with the diagnostic testing (whole exome sequencing/WES) on amniotic fluid/placenta tissue/umbilical cord blood samples. Single-gene NIPT detected pathogenic variants in the fetuses on TSC2, FGFR3, FGFR2 (two cases), and PTPN11 genes. All results coincided with the subsequent diagnosis. Preliminary research showed the potential of cell-free fetal DNA analysis for prenatal screening of dominant single-gene mutations.
Chi tiết bài viết
Từ khóa
Single-gene disorders, NIPT-SGD, TSC2, FGFR3, FGFR2, PTPN11
Tài liệu tham khảo
2. Zhang J, Li J, Saucier JB, et al. Non-invasive prenatal sequencing for multiple Mendelian monogenic disorders using circulating cell-free fetal DNA. Nat Med. 2019; 25(3): 439-447. doi:10.1038/s41591-018-0334-x.
3. Mohan P, Lemoine J, Trotter C, et al. Clinical experience with non-invasive prenatal screening for single-gene disorders. Ultrasound Obstet Gynecol. 2022; 59(1): 33-39. doi:10.1002/uog.23756.
4. Phuoc Loc D, Vu Uyen T, Canh Chuong N, et al. Establishment and evaluation of non-invasive prenatal screening process for common dominant single-gene disorders.Journal: Vietnam Medical Journal.2022.- 513/1. DOI: 10.51298/vmj.v513i1.2342.
5. Rahbari R, Wuster A, Lindsay SJ, et al. Timing, rates and spectra of human germline mutation. Nat Genet. 2016; 48(2): 126-133. doi:10.1038/ng.3469.
6. Chitty LS, Mason S, Barrett AN, et al. Non-invasive prenatal diagnosis of achondroplasia and thanatophoric dysplasia: next-generation sequencing allows for a safer, more accurate, and comprehensive approach. Prenat Diagn. 2015; 35(7): 656-662. doi:10.1002/PD.4583.
7. Dan S, Yuan Y, Wang Y, et al. Non-Invasive Prenatal Diagnosis of Lethal Skeletal Dysplasia by Targeted Capture Sequencing of Maternal Plasma. PloS One. 2016; 11(7): e0159355. doi:10.1371/journal.pone.0159355.
8. Benn P, Mohan P, Krinshpun S, Lemoine J. VP08.02: Noonan syndrome screening by non-invasive prenatal testing for single-gene disorders. Ultrasound Obstet Gynecol. 2020; 56(S1): 81-81. doi:10.1002/uog.22432.